Research shows that once the medication is stopped, weight regain is common, often rapid, because the underlying drivers remain untouched (Quarenghi et al
Tirzepatide is an established, FDA-approved treatment with real-world outcomes, while Retatrutide remains investigational
Interestingly, in some cells of the ARC nucleus, it is also possible to find neuropeptide receptors (molecules with a role in the regulation of calorie intake) together with GIP-R, probably implicated in the regulation of food intake
Cardiovascular symptoms Some people taking liraglutide will notice a slight increase in resting heart rate, about 2 to 3 beats per minute
Taking semaglutide and liraglutide together is not safe because the drugs work in the same way
Important Legal and Regulatory Information: Not FDA-Approved: Dihexa is not approved to treat memory loss, cognitive decline, neurodegenerative disease, learning difficulties, or any medical condition